Genetic Regulation of Cardiac Septation
Genetic Regulation of Cardiac Septation
批准号:
7469434
负责人:
Vidu Garg
金额:
$39.25万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-16 至 2012-04-30
关键词:
8p22AccountingAffectAllelesBloodCardiacCause of DeathCell LineageCodon NucleotidesConditionCongenital AbnormalityCongenital Heart DefectsCritical PathwaysDNA BindingDNA-Binding ProteinsDataDefectDevelopmentDevelopmental ProcessDiseaseEmbryoEmbryonic DevelopmentEtiologyFamily memberGene TargetingGenerationsGenesGeneticGenetic Predisposition to DiseaseGlycineGoalsHeartHeart AtriumHeart Septal DefectsHeart failureHolt Oram syndromeHumanIn VitroIndividualLifeLife ExpectancyLimb structureLive BirthLungMapsMediatingMesenchymalMolecularMusMutationMyocardiumPathway interactionsPatientsPatternPhenotypePlayPoint MutationProcessProteinsRegulationResearchResearch PersonnelRoleSerineSignaling Pathway GeneUrinationVascular DiseasesVentricular Septal DefectsZinc Fingersatrioventricular septal defectbasecardiogenesiscell typecongenital heart disordergenetic linkage analysisgenetic pedigreegenome-wide linkagein vivomutantnovelprogramsprotein protein interactionsmoothened signaling pathwaytranscription factor
中文摘要
描述(申请人提供):先天性心脏病(CHD)是最常见的出生缺陷类型,发生在近1%的活产婴儿中。心间隔缺损占冠心病的近50%。大多数冠心病有多因素起源,但越来越多的证据表明遗传因素起着重要作用。家族性冠心病罕见病例的鉴定有助于揭示遗传病因。我们研究的长期目标是了解人类冠心病遗传病因的分子途径。利用全基因组连锁分析,我们发现了编码锌指转录因子对心脏正常发育至关重要的GATA4的点突变,这种突变与心间隔缺损和其他心脏畸形有关。在一个大型冠心病家系中,GATA4 G296S突变揭示了GATA4与TBX5之间一种新的功能相互作用,TBX5是以冠心病为特征的Holt-Oram综合征的遗传原因。与这一体外发现一致,Gata4和Tbx5表现出遗传相互作用,因为Gata4和Tbx5杂合的小鼠具有独特的心脏表型,这是由心内膜缓冲发育缺陷引起的。这些发现为我们剖析导致冠心病的分子通路提供了切入点。虽然Gata4和Tbx5以及其他转录因子在心脏发育和冠心病中发挥核心作用是显而易见的,但对介导这些发育调节因子作用的靶基因的理解仍是一个重大空白。这是本提案的重要目标之一。总体假设是GATA4和TBX5调节对心脏分离和其他心脏形态发生过程至关重要的共同途径。本建议的目的是:具体目标1。确定Gata4-Tbx5相互作用是导致Gata4 Tbx5胚胎心脏缺陷所必需的发育过程和细胞谱系。具体目标2。了解Hedgehog信号通路在Gata4 Tbx5胚胎心脏表型中的作用。具体目标3。确定Gata4 G296S突变蛋白在胚胎发生中的作用。将产生在Gata4中携带G296S突变的小鼠,并用于确定该点突变的分子和功能在体内的缺陷。
英文摘要
DESCRIPTION (provided by applicant): Congenital heart disease (CHD) is the most common type of birth defect occurring in nearly 1% of live births. Cardiac septation defects account for nearly 50% of CHD. The majority of CHD has a multifactorial origin but increasing evidence suggests that genetic factors play a significant role. The identification of rare cases of familial CHD has been instrumental in uncovering genetic etiologies. The long-term goal of our research is to understand the molecular pathways that underlie the genetic etiologies of human CHD. Utilizing genome-wide linkage analysis, we discovered point mutations in GATA4, which encodes a zinc finger transcription factor critical for normal cardiac development, that were associated with cardiac septal defects and other cardiac malformations. A GATA4 G296S mutation in a large pedigree with CHD revealed a novel functional interaction between GATA4 and TBX5, the genetic cause of Holt-Oram syndrome that is characterized by CHD. Consistent with this in vitro finding, Gata4 and Tbx5 displayed a genetic interaction as mice heterozygous for Gata4 and Tbx5 have a unique cardiac phenotype that results from defective endocardial cushion development. These findings allowed us an entry point to dissect the molecular pathways that are disrupted leading to CHD. While it is clear that Gata4 and Tbx5, as well as other transcription factors, play central roles in cardiac development and CHD, there is a major void in the understanding of the target genes that mediate the actions of these developmental regulators. This is one of the important goals of this proposal. The overall hypothesis is that GATA4 and TBX5 regulate common pathways critical for cardiac septation and other cardiac morphogenetic processes. The aims of this proposal are: Specific Aim 1. To determine the developmental processes and cell lineage(s) in which Gata4-Tbx5 interaction is necessary to result in cardiac defects seen in Gata4 Tbx5 embryos. Specific Aim 2. To understand the role of the Hedgehog signaling pathway in the cardiac phenotype of the Gata4 Tbx5 embryos. Specific Aim 3. To determine the role of the Gata4 G296S mutant protein during embryogenesis. Mice that harbor the G296S mutation in Gata4 will be generated and used to define the molecular and functional in vivo deficits of this point mutation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Multi-omic approach towards improving candidate gene identification and variant prioritization in patients with congenital heart disease
-
批准号:10360965
-
项目类别:
-
资助金额:$11.55万
-
财政年份:2022
-
负责人:Vidu Garg
-
依托单位:
A Multi-omic approach towards improving candidate gene identification and variant prioritization in patients with congenital heart disease
-
批准号:10544032
-
项目类别:
-
资助金额:$11.55万
-
财政年份:2022
-
负责人:Vidu Garg
-
依托单位:
Epigenetic Mechanisms Underlying Maternal Diabetes Associated Cardiac Malformations
-
批准号:9816152
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2019
-
负责人:Vidu Garg
-
依托单位:
Epigenetic Mechanisms Underlying Maternal Diabetes Associated Cardiac Malformations
-
批准号:10202715
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2019
-
负责人:Vidu Garg
-
依托单位:
Epigenetic Mechanisms Underlying Maternal Diabetes Associated Cardiac Malformations
-
批准号:10462586
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2019
-
负责人:Vidu Garg
-
依托单位:
Weinstein Cardiovascular Development Conference
-
批准号:9261292
-
项目类别:
-
资助金额:$2.1万
-
财政年份:2017
-
负责人:Vidu Garg
-
依托单位:
The Role of Notch in Calcific Aortic Valve Disease
-
批准号:9143866
-
项目类别:
-
资助金额:$67.71万
-
财政年份:2016
-
负责人:Vidu Garg
-
依托单位:
Molecular Mechanisms of Aortic Valve Formation
-
批准号:8915429
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2015
-
负责人:Vidu Garg
-
依托单位:
Exome sequencing and functional studies in familial CHD
-
批准号:8892228
-
项目类别:
-
资助金额:$64.95万
-
财政年份:2012
-
负责人:Vidu Garg
-
依托单位:
Exome sequencing and functional studies in familial CHD
-
批准号:8297881
-
项目类别:
-
资助金额:$69.56万
-
财政年份:2012
-
负责人:Vidu Garg
-
依托单位:
Exome sequencing and functional studies in familial CHD
-
批准号:8550126
-
项目类别:
-
资助金额:$66.91万
-
财政年份:2012
-
负责人:Vidu Garg
-
依托单位:
Exome sequencing and functional studies in familial CHD
-
批准号:8708537
-
项目类别:
-
资助金额:$66.4万
-
财政年份:2012
-
负责人:Vidu Garg
-
依托单位:
Training in Congenital and Acquired Heart Disease
-
批准号:9766876
-
项目类别:
-
资助金额:$2.83万
-
财政年份:2009
-
负责人:Vidu Garg
-
依托单位:
Training in Congenital and Acquired Heart Disease
-
批准号:9304327
-
项目类别:
-
资助金额:$33.34万
-
财政年份:2009
-
负责人:Vidu Garg
-
依托单位:
Training in Congenital and Acquired Heart Disease
-
批准号:8935000
-
项目类别:
-
资助金额:$30.64万
-
财政年份:2009
-
负责人:Vidu Garg
-
依托单位:
Genetic Regulation of Cardiac Septation
-
批准号:7613484
-
项目类别:
-
资助金额:$15.05万
-
财政年份:2007
-
负责人:Vidu Garg
-
依托单位:
Genetic Regulation of Cardiac Septation
-
批准号:7981793
-
项目类别:
-
资助金额:$24.2万
-
财政年份:2007
-
负责人:Vidu Garg
-
依托单位:
Genetic Regulation of Cardiac Septation
-
批准号:7319005
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2007
-
负责人:Vidu Garg
-
依托单位:
Genetic Regulation of Cardiac Septation
-
批准号:7793594
-
项目类别:
-
资助金额:$36.0万
-
财政年份:2007
-
负责人:Vidu Garg
-
依托单位:
Genetic Regulation of Cardiac Septation
-
批准号:8070520
-
项目类别:
-
资助金额:$36.0万
-
财政年份:2007
-
负责人:Vidu Garg
-
依托单位:
海外基金